Phyllodes tumors of the breast: The role of pathologic parameters

American Journal of Clinical Pathology

Volumn 123, Issue 4, 2005, Pages 529-540

  Tan, Puay Hoon ^a   Jayabaskar, Thiyagarajan ^b   Chuah, Khoon Leong ^a   Lee, Hwei Yee ^a   Tan, Yen ^c   Hilmy, Maryam ^a   Hung, Huynh ^c   Selvarajan, Sathiyamoorthy ^a   Bay, Boon Huat ^b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Grade; Pseudoangiomatous stromal hyperplasia; Recurrence; Surgical margins

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; BREAST TUMOR; CYSTOSARCOMA PHYLLOIDES; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; SINGAPORE; TUMOR CLASSIFICATION; TUMOR RECURRENCE;

EID: 15744372047     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/U6DVBFM81MLJC1FN     Document Type: Article

References (37)

1. Feakins RM, Mulcahy HE, Nickols CD, et al. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome. Histopathology. 1999;35:162-169.
2. Keelan PA, Myers JL, Wold LE, et al. Phyllodes tumor: clinicopathologic review of 60 patients and flow cytometric analysis in 30 patients. Hum Pathol 1992;23:1048-1054.
3. Kuijper A, Buerger H, Simon R, et al. Analysis of the progression of fibroepithelial tumours of the breast by PCR- based clonality assay. J Pathol. 2002;197:575-581.
4. Noguchi S, Yokouchi H, Aihara T, et al. Progression of fibroadenoma to phyllodes tumor demonstrated by clonal analysis. Cancer. 1995;76:1779-1785.
5. Zurrida S, Bartoli C, Galimberti V, et al. Which therapy for unexpected phyllode tumour of the breast? Eur J Cancer. 1992;28:654-657.
6. Moffat CJC, Finder SE, Dixon AR, et al. Phyllodes tumours of the breast: a clinicopathological review of thirty-two cases. Histopathology. 1995;27:205-218.
7. Reinfuss M, Mitus J, Smolak K, et al. Malignant phyllodes tumours of the breast: a clinical and pathological analysis of 55 cases. Eur J Cancer. 1993;29A:1252-1256.
8. Reinfuss M, Mitus J, Duda K, et al. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer. 1996;77:910-916.
9. Chaney AW, Pollack A, McNeese MD, et al. Primary treatment of cystosarcoma phyllodes of the breast. Cancer. 2000;89:1502-1511.
10. Hawkins RE, Schofield JB, Fisher C, et al. The clinical and histologic criteria that predict metastases from cystosarcoma phyllodes. Cancer. 1992;69:141-147.
11. Cohn-Cedermark G, Rutqvist LE, Rosendahl I, et al. Prognostic factors in cystosarcoma phyllodes: a clinicopathologic study of 77 patients. Cancer. 1991;68:2017-2022.
12. Pietruszka M, Barnes L. Cystosarcoma phyllodes: a clinicopathologic analysis of 42 cases. Cancer. 1978;41:1974-1983.
13. Barth RJ Jr. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat. 1999;57:291-295.
14. Kleer CG, Giordano TJ, Braun T, et al. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast. Mod Pathol. 2001;14:185-190.
15. Norris HJ, Taylor HB. Relationship of histologic features to behavior of cystosarcoma phyllodes: analysis of ninety-four cases. Cancer. 1967;20:2090-2099.
16. Ward RM, Evans HL. Cystosarcoma phyllodes: a clinicopathologic study of 26 cases. Cancer. 1986;58:2282-2289.
17. Lester J, Stout AP. Cystosarcoma phyllodes. Cancer. 1954;7:335-353.
18. Oberman HA. Cystosarcoma phyllodes: a clinicopathologic study of hypercellular periductal stromal neoplasms of breast. Cancer. 1965;18:697-710.
19. Treves N, Sunderland DA. Cystosarcoma phyllodes of the breast: a malignant and a benign tumor: a clinicopathological study of seventy-seven cases. Cancer. 1951;4:1286-1332.
20. Rosen PP. Fibroepithelial neoplasms. In: Rosen's Breast Pathology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:163-200.
21. Powell CM, Cranor ML, Rosen PP. Pseudoangiomatous stromal hyperplasia (PASH): a mammary stromal tumor with myofibroblastic differentiation. Am J Surg Pathol. 1995;19:270-277.
22. Sawhney N, Garrahan N, Douglas-Jones AG, et al. Epithelial-stromal interactions in tumors: a morphologic study of fibroepithelial tumors of the breast. Cancer. 1992;70:2115-2120.
23. Sawyer EJ, Hanby AM, Ellis P, et al. Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components. Am J Pathol. 2000;156:1093-1098.
24. Sawyer EJ, Hanby AM, Rowan AJ, et al. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours. J Pathol. 2002;196:437-444.
25. Powell CM, Cranor ML, Rosen PP. Multinucleated stromal giant cells in mammary fibroepithelial neoplasms: a study of 11 patients. Arch Pathol Lab Med. 1994;118:912-916.
26. Tse GM, Law BK, Chan KF, et al. Multinucleated stromal giant cells in mammary phyllodes tumors. Pathology. 2001;33:153-156.
27. Hiraoka N, Mukai M, Hosoda Y, et al. Phyllodes tumor of the breast containing the intracytoplasmic inclusion bodies identical with infantile digital fibromatosis. Am J Surg Pathol. 1994;18:506-511.
28. Kuenen-Boumeester V, Henzen-Logmans SC, Timmermans MM, et al. Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast. J Pathol. 1999;189:169-175.
29. Niezabitowski A, Lackowska B, Rys J, et al. Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases. Breast Cancer Res Treat. 2001;65:77-85.
30. Witte F, Honig A, Mirecka J, et al. Cystosarcoma phyllodes of the breast: prognostic significance of proliferation and apoptosis associated genes. Anticancer Res. 1999;9:3355-3360.
31. Tse GMK, Ma TKF, Chan KF, et al. Increased microvessel density in malignant and borderline mammary phyllodes tumours. Histopathology. 2001;38:567-570.
32. Silverman JS, Tamsen A. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages. Histopathology. 1996;29:411-419.
33. Millar EKA, Beretov J, Marr P, et al. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression. Histopathology. 1999;34:491-496.
34. Tse GMK, Putti TC, Kung FYL, et al. Increased p53 protein expression in malignant mammary phyllodes tumors. Mod Pathol. 2002;15:734-740.
35. Sawyer EJ, Poulsom R, Hunt FT, et al. Malignant phyllodes tumors show stromal overexpression of c-myc and c-kit. J Pathol. 2003;200:59-64.
36. Elston CW, Ellis IO. Fibroadenoma and related conditions. In: Elston CW, Ellis IO, eds. The Breast. Edinburgh, Scotland: Churchill Livingstone; 1998:168-186.
37. Lau PTC, Lim TC, Png DJC, et al. Phyllodes tumour: an update of 40 cases. Ann Acad Med Singapore. 1998;27:200-203.